BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 953642 COCCOCCOCCO[C@H]1CC[C@H]2[C@H]3Cc4ccc(OC)cc4[C@@]2(CCN3C)C1 InChI=1S/C25H39NO5/c1-26-9-8-25-18-21(31-15-14-30-13-12-29-11-10-27-2)6-7-22(25)24(26)16-19-4-5-20(28-3)17-23(19)25/h4-5,17,21-22,24H,6-16,18H2,1-3H3/t21-,22-,24+,25-/m0/s1 MIDZVHCKABPONF-HFOXQMJASA-N 461934 Preparation of (6α)-3-methoxy-6-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-17-methylmorphinan ::US10766864, Example 1 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461934&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689998 441293158 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953643 COCCOCCOCCOCCOCCO[C@H]1CC[C@H]2[C@H]3Cc4ccc(OC)cc4[C@@]2(CCN3C)C1 InChI=1S/C29H47NO7/c1-30-9-8-29-22-25(6-7-26(29)28(30)20-23-4-5-24(32-3)21-27(23)29)37-19-18-36-17-16-35-15-14-34-13-12-33-11-10-31-2/h4-5,21,25-26,28H,6-20,22H2,1-3H3/t25-,26-,28+,29-/m0/s1 ZXWJGDMZATVFSQ-KGKLHAENSA-N 461935 Preparation of (6α)-3-methoxy-17-methyl-6-(2,5,8,11,14-pentaoxahexadecan-16-yloxy)morphinan ::US10766864, Example 2 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461935&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690060 441293159 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953644 COCCN1CC[C@]23CC(=O)CC[C@H]2[C@H]1Cc1ccc(O)cc31 InChI=1S/C19H25NO3/c1-23-9-8-20-7-6-19-12-15(22)4-5-16(19)18(20)10-13-2-3-14(21)11-17(13)19/h2-3,11,16,18,21H,4-10,12H2,1H3/t16-,18+,19-/m0/s1 ICQVSCFBXDCNMW-UHOSZYNNSA-N 461936 Preparation of 3-hydroxy-17-(2-methoxyethyl)morphinan-6-one ::US10766864, Example 3 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461936&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690086 441293160 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953645 COCCOCCOCCN1CC[C@]23CC(=O)CC[C@H]2[C@H]1Cc1ccc(OC)cc31 InChI=1S/C24H35NO5/c1-27-11-12-30-14-13-29-10-9-25-8-7-24-17-19(26)4-6-21(24)23(25)15-18-3-5-20(28-2)16-22(18)24/h3,5,16,21,23H,4,6-15,17H2,1-2H3/t21-,23+,24-/m0/s1 RLFMTANMPKXMFQ-QTJGBDASSA-N 461937 Preparation of 3-methoxy-17-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}morphinan-6-one ::US10766864, Example 4 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461937&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690063 441293161 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953646 COCCOCCN1CC[C@]23CC(=O)CC[C@H]2[C@H]1Cc1ccc(OC)cc31 InChI=1S/C22H31NO4/c1-25-11-12-27-10-9-23-8-7-22-15-17(24)4-6-19(22)21(23)13-16-3-5-18(26-2)14-20(16)22/h3,5,14,19,21H,4,6-13,15H2,1-2H3/t19-,21+,22-/m0/s1 HLGHCTKNMLXKNC-NNWRFLSQSA-N 461938 Preparation of 3-methoxy-17-[2-(2-methoxyethoxy)ethyl]morphinan-6-one ::US10766864, Example 5 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461938&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689981 441293162 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953647 COCCOCCOCCN1CC[C@]23CC(=O)CC[C@H]2[C@H]1Cc1ccc(O)cc31 InChI=1S/C23H33NO5/c1-27-10-11-29-13-12-28-9-8-24-7-6-23-16-19(26)4-5-20(23)22(24)14-17-2-3-18(25)15-21(17)23/h2-3,15,20,22,25H,4-14,16H2,1H3/t20-,22+,23-/m0/s1 NPXLSLUYOKNJLW-WWNPGLIZSA-N 461939 Preparation of 3-hydroxy-17-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}morphinan-6-one ::US10766864, Example 6 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461939&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690005 441293163 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953648 COCCOc1ccc2C[C@@H]3[C@@H]4CCC(=O)C[C@]4(CCN3C)c2c1 InChI=1S/C20H27NO3/c1-21-8-7-20-13-15(22)4-6-17(20)19(21)11-14-3-5-16(12-18(14)20)24-10-9-23-2/h3,5,12,17,19H,4,6-11,13H2,1-2H3/t17-,19+,20-/m0/s1 NUGWTXRFQKNOJH-SXLOBPIMSA-N 461940 Preparation of 3-(2-methoxyethoxy)-17-methylmorphinan-6-one ::US10766864, Example 7 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461940&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690078 441293164 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953649 COCCOCCOCCOCCOCCOc1ccc2C[C@@H]3[C@@H]4CCC(=O)C[C@]4(CCN3C)c2c1 InChI=1S/C28H43NO7/c1-29-8-7-28-21-23(30)4-6-25(28)27(29)19-22-3-5-24(20-26(22)28)36-18-17-35-16-15-34-14-13-33-12-11-32-10-9-31-2/h3,5,20,25,27H,4,6-19,21H2,1-2H3/t25-,27+,28-/m0/s1 FPNXHBQFPMNCRT-ITHJLQSDSA-N 461941 Preparation of 17-methyl-3-(2,5,8,11,14-pentaoxahexadecan-16-yloxy)morphinan-6-one ::US10766864, Example 8 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461941&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690070 441293165 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953650 COCCOCCOCCO[C@H]1CC[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3C)C1 InChI=1S/C24H37NO5/c1-25-8-7-24-17-20(30-14-13-29-12-11-28-10-9-27-2)5-6-21(24)23(25)15-18-3-4-19(26)16-22(18)24/h3-4,16,20-21,23,26H,5-15,17H2,1-2H3/t20-,21-,23+,24-/m0/s1 DRVQXPKAWCJOJN-ZQRMPTRQSA-N 461942 Preparation of (6α)-6-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-17-methylmorphinan-3-ol ::US10766864, Example 9 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461942&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690025 441293166 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953651 COCCOCCOCCOCCOCCO[C@H]1CC[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3C)C1 InChI=1S/C28H45NO7/c1-29-8-7-28-21-24(5-6-25(28)27(29)19-22-3-4-23(30)20-26(22)28)36-18-17-35-16-15-34-14-13-33-12-11-32-10-9-31-2/h3-4,20,24-25,27,30H,5-19,21H2,1-2H3/t24-,25-,27+,28-/m0/s1 CXEZQVZGASVAQE-KWNVVKLJSA-N 461943 Preparation of (6α)-17-methyl-6-(2,5,8,11,14-pentaoxahexadecan-16-yloxy)morphinan-3-ol ::US10766864, Example 10 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461943&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690073 441293167 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953652 COCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(OC)cc31 InChI=1S/C20H29NO2/c1-22-12-11-21-10-9-20-8-4-3-5-17(20)19(21)13-15-6-7-16(23-2)14-18(15)20/h6-7,14,17,19H,3-5,8-13H2,1-2H3/t17-,19+,20+/m0/s1 LRAIXHDABSIHIJ-DFQSSKMNSA-N 461944 Preparation of 3-methoxy-17-(2-methoxyethyl)-morphinan ::US10766864, Example 11 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461944&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689994 441293168 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953653 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(OC)cc31 InChI=1S/C22H33NO3/c1-24-13-14-26-12-11-23-10-9-22-8-4-3-5-19(22)21(23)15-17-6-7-18(25-2)16-20(17)22/h6-7,16,19,21H,3-5,8-15H2,1-2H3/t19-,21+,22+/m0/s1 GUPDFNBMKUJOIE-KSEOMHKRSA-N 461945 Preparation of 3-methoxy-17-[2-(2-methoxyethoxy)ethyl]-morphinan ::US10766864, Example 12 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461945&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690027 441293169 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953654 COCCOCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(OC)cc31 InChI=1S/C24H37NO4/c1-26-13-14-29-16-15-28-12-11-25-10-9-24-8-4-3-5-21(24)23(25)17-19-6-7-20(27-2)18-22(19)24/h6-7,18,21,23H,3-5,8-17H2,1-2H3/t21-,23+,24+/m0/s1 ODXDEZRJGFXEIM-QPTUXGOLSA-N 461946 Preparation of 3-methoxy-17-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-morphinan ::US10766864, Example 13 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461946&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689990 441293170 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953655 COCCOCCOCCOCCOCCOc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C28H45NO6/c1-29-10-9-28-8-4-3-5-25(28)27(29)21-23-6-7-24(22-26(23)28)35-20-19-34-18-17-33-16-15-32-14-13-31-12-11-30-2/h6-7,22,25,27H,3-5,8-21H2,1-2H3/t25-,27+,28+/m0/s1 SPKGRYPBZGYRLT-KJYTXNCISA-N 461947 Preparation of 17-methyl-3-(2,5,8,11,14-pentaoxahexadecan-16-yloxy)morphinan ::US10766864, Example 14 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461947&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690104 441293171 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953656 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc31 InChI=1S/C21H31NO3/c1-24-12-13-25-11-10-22-9-8-21-7-3-2-4-18(21)20(22)14-16-5-6-17(23)15-19(16)21/h5-6,15,18,20,23H,2-4,7-14H2,1H3/t18-,20+,21+/m0/s1 VIFACTNVEJWRQH-CEWLAPEOSA-N 461948 Preparation of 17-[2-(2-methoxyethoxy)ethyl]morphinan-3-ol ::US10766864, Example 15 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461948&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690045 441293172 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953657 COCCOCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc31 InChI=1S/C23H35NO4/c1-26-12-13-28-15-14-27-11-10-24-9-8-23-7-3-2-4-20(23)22(24)16-18-5-6-19(25)17-21(18)23/h5-6,17,20,22,25H,2-4,7-16H2,1H3/t20-,22+,23+/m0/s1 SSGWIHUDOROWPI-MDNUFGMLSA-N 461949 Preparation of 17-{2-{2-(2-methoxyethoxy)ethoxy]ethyl}-morphinan-3-ol ::US10766864, Example 16 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461949&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690055 441293173 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953658 CCNC(=O)N1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(OC)cc31 InChI=1S/C20H28N2O2/c1-3-21-19(23)22-11-10-20-9-5-4-6-16(20)18(22)12-14-7-8-15(24-2)13-17(14)20/h7-8,13,16,18H,3-6,9-12H2,1-2H3,(H,21,23)/t16-,18+,20+/m0/s1 YITARTGBZDDOOQ-ILZDJORESA-N 461950 Preparation of N-ethyl-3-methoxymorphinan-17-carboxamide ::US10766864, Example 17 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461950&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690092 441293174 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953659 COCCNC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C21H30N2O3/c1-23-11-9-21-8-4-3-5-17(21)19(23)13-15-6-7-16(14-18(15)21)26-20(24)22-10-12-25-2/h6-7,14,17,19H,3-5,8-13H2,1-2H3,(H,22,24)/t17-,19+,21+/m0/s1 OZNMIGSWQZSRCV-FBBABVLZSA-N 461951 Preparation of 17-methylmorphinan-3-yl (2-methoxyethyl)carbamate ::US10766864, Example 18 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461951&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134486939 441293175 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953660 COCCOc1c(OC)ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c12 InChI=1S/C21H31NO3/c1-22-11-10-21-9-5-4-6-16(21)17(22)14-15-7-8-18(24-3)20(19(15)21)25-13-12-23-2/h7-8,16-17H,4-6,9-14H2,1-3H3/t16-,17+,21+/m0/s1 OPWOWJMSDHCWEE-CSODHUTKSA-N 461952 Preparation of 3-methoxy-4-(2-methoxyethoxy)-17-methylmorphinan ::US10766864, Example 21 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461952&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690103 441293176 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953661 COCCOc1c(O)ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c12 InChI=1S/C20H29NO3/c1-21-10-9-20-8-4-3-5-15(20)16(21)13-14-6-7-17(22)19(18(14)20)24-12-11-23-2/h6-7,15-16,22H,3-5,8-13H2,1-2H3/t15-,16+,20+/m0/s1 QUWJBORBZNAHJA-RZQQEMMASA-N 461953 Preparation of 4-(2-methoxyethoxy)-17-methylmorphinan-3-ol ::US10766864, Example 22 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461953&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690020 441293177 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953662 COCCNC(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C21H31N3O2/c1-24-11-9-21-8-4-3-5-17(21)19(24)13-15-6-7-16(14-18(15)21)23-20(25)22-10-12-26-2/h6-7,14,17,19H,3-5,8-13H2,1-2H3,(H2,22,23,25)/t17-,19+,21+/m0/s1 RCYREOBORCBBRB-FBBABVLZSA-N 461954 Preparation of 1-(2-methoxyethyl)-3-(17-methylmorphinan-3-yl)urea ::US10766864, Example 23 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461954&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690097 441293178 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953663 COc1ccc(cc1)C(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C25H30N2O2/c1-27-14-13-25-12-4-3-5-21(25)23(27)15-18-6-9-19(16-22(18)25)26-24(28)17-7-10-20(29-2)11-8-17/h6-11,16,21,23H,3-5,12-15H2,1-2H3,(H,26,28)/t21-,23+,25+/m0/s1 CEJINZMFZRZSGC-QQKQFIJSSA-N 461955 Preparation of 4-methoxy-N-((4bR,8aR,9R)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-yl)benzamide ::US10766864, Example 24 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461955&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695627 441293179 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953664 COc1cccc(c1)C(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C25H30N2O2/c1-27-13-12-25-11-4-3-8-21(25)23(27)15-17-9-10-19(16-22(17)25)26-24(28)18-6-5-7-20(14-18)29-2/h5-7,9-10,14,16,21,23H,3-4,8,11-13,15H2,1-2H3,(H,26,28)/t21-,23+,25+/m0/s1 HLQJYWFNRUZHGG-QQKQFIJSSA-N 461956 Preparation of 3-methoxy-N-((4bR,8aR,9R)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-yl)benzamide ::US10766864, Example 25 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461956&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695594 441293180 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953665 COc1ccccc1C(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C25H30N2O2/c1-27-14-13-25-12-6-5-8-20(25)22(27)15-17-10-11-18(16-21(17)25)26-24(28)19-7-3-4-9-23(19)29-2/h3-4,7,9-11,16,20,22H,5-6,8,12-15H2,1-2H3,(H,26,28)/t20-,22+,25+/m0/s1 PLKAGRHICCXNTD-NIRIFSCTSA-N 461957 Preparation of 2-methoxy-N-((4bR,8aR,9R)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-yl)benzamide ::US10766864, Example 26 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461957&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695595 441293181 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953666 COc1ccc(NC(=O)Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)cc1 InChI=1S/C25H31N3O2/c1-28-14-13-25-12-4-3-5-21(25)23(28)15-17-6-7-19(16-22(17)25)27-24(29)26-18-8-10-20(30-2)11-9-18/h6-11,16,21,23H,3-5,12-15H2,1-2H3,(H2,26,27,29)/t21-,23+,25+/m0/s1 WIIMPRKEDQVPGR-QQKQFIJSSA-N 461958 Preparation of 1-(4-methoxyphenyl)-3-(17-methylmorphinan-3-yl)urea ::US10766864, Example 27 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461958&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690083 441293182 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953667 COc1ccc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)cc1 InChI=1S/C24H30N2O/c1-26-14-13-24-12-4-3-5-21(24)23(26)15-17-6-7-19(16-22(17)24)25-18-8-10-20(27-2)11-9-18/h6-11,16,21,23,25H,3-5,12-15H2,1-2H3/t21-,23+,24+/m0/s1 JZUCFHJFDSJMAK-QPTUXGOLSA-N 461959 Preparation of N-(4-methoxyphenyl)-17-methylmorphinan-3-amine ::US10766864, Example 28 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461959&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689988 441293183 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953668 COc1cccc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)c1 InChI=1S/C24H30N2O/c1-26-13-12-24-11-4-3-8-21(24)23(26)14-17-9-10-19(16-22(17)24)25-18-6-5-7-20(15-18)27-2/h5-7,9-10,15-16,21,23,25H,3-4,8,11-14H2,1-2H3/t21-,23+,24+/m0/s1 QDYVRQAKSXHGIS-QPTUXGOLSA-N 461960 Preparation of N-(3-methoxyphenyl)-17-methylmorphinan-3-amine ::US10766864, Example 29 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461960&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690105 441293184 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953669 COc1ccccc1Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C24H30N2O/c1-26-14-13-24-12-6-5-7-19(24)22(26)15-17-10-11-18(16-20(17)24)25-21-8-3-4-9-23(21)27-2/h3-4,8-11,16,19,22,25H,5-7,12-15H2,1-2H3/t19-,22+,24+/m0/s1 QWEAALVMRRNHNP-BPUDTRNYSA-N 461961 Preparation of N-(2-methoxyphenyl)-17-methylmorphinan-3-amine ::US10766864, Example 30 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461961&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690051 441293185 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953670 COCCO[C@@H]1CCC2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3C)C1 InChI=1S/C20H29NO3/c1-21-8-7-20-13-16(24-10-9-23-2)5-6-17(20)19(21)11-14-3-4-15(22)12-18(14)20/h3-4,12,16-17,19,22H,5-11,13H2,1-2H3/t16-,17?,19-,20+/m1/s1 CMKSOXCXFNUNTI-FQVATPOOSA-N 461962 Preparation of (6β)-6-(2-methoxyethoxy)-17-methylmorphinan-3-ol ::US10766864, Example 31 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461962&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695558 441293186 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953671 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ncccn2)cc31 InChI=1S/C21H26N4/c1-25-12-9-21-8-3-2-5-17(21)19(25)13-15-6-7-16(14-18(15)21)24-20-22-10-4-11-23-20/h4,6-7,10-11,14,17,19H,2-3,5,8-9,12-13H2,1H3,(H,22,23,24)/t17-,19+,21+/m0/s1 HZXNFFUIEXCYPN-FBBABVLZSA-N 461963 Preparation of 17-methyl-N-(pyrimidin-2-yl)morphinan-3-amine ::US10766864, Example 32 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461963&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690041 441293187 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953672 COCCOCCOCC(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C24H36N2O4/c1-26-10-9-24-8-4-3-5-20(24)22(26)15-18-6-7-19(16-21(18)24)25-23(27)17-30-14-13-29-12-11-28-2/h6-7,16,20,22H,3-5,8-15,17H2,1-2H3,(H,25,27)/t20-,22+,24+/m0/s1 YLKHAAVXMAEWDZ-BGWNEDDSSA-N 461964 Preparation of 2-[2-(2-methoxyethoxy)ethoxy]-N-(17-methylmorphinan-3-yl)acetamide ::US10766864, Example 33 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461964&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690090 441293188 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953673 COCCOCCOc1cccc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)c1 InChI=1S/C28H38N2O3/c1-30-13-12-28-11-4-3-8-25(28)27(30)18-21-9-10-23(20-26(21)28)29-22-6-5-7-24(19-22)33-17-16-32-15-14-31-2/h5-7,9-10,19-20,25,27,29H,3-4,8,11-18H2,1-2H3/t25-,27+,28+/m0/s1 CXLWIGWRFVFUFO-KJYTXNCISA-N 461965 Preparation of N-{3-[2-(2-methoxyethoxy)ethoxy]phenyl}-17-methylmorphinan-3-amine ::US10766864, Example 34 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461965&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690076 441293189 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953674 COCCOCCOc1ccccc1Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C28H38N2O3/c1-30-14-13-28-12-6-5-7-23(28)26(30)19-21-10-11-22(20-24(21)28)29-25-8-3-4-9-27(25)33-18-17-32-16-15-31-2/h3-4,8-11,20,23,26,29H,5-7,12-19H2,1-2H3/t23-,26+,28+/m0/s1 CEQLFVOLZBFJDV-DANFDKMISA-N 461966 Preparation of N-{2-[2-(2-methoxyethoxy)ethoxy]phenyl}-17-methylmorphinan-3-amine ::US10766864, Example 35 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461966&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690021 441293190 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953675 COCCOCCOc1ccc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)cc1 InChI=1S/C28H38N2O3/c1-30-14-13-28-12-4-3-5-25(28)27(30)19-21-6-7-23(20-26(21)28)29-22-8-10-24(11-9-22)33-18-17-32-16-15-31-2/h6-11,20,25,27,29H,3-5,12-19H2,1-2H3/t25-,27+,28+/m0/s1 ZAIGWOQRNCFKSB-KJYTXNCISA-N 461967 N-{4-[2-(2-methoxyethoxy)ethoxy]phenyl}-17-methylmorphinan-3-amine ::US10766864, Example 36 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461967&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690048 441293191 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953676 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(NS(C)(=O)=O)cc31 InChI=1S/C18H26N2O2S/c1-20-10-9-18-8-4-3-5-15(18)17(20)11-13-6-7-14(12-16(13)18)19-23(2,21)22/h6-7,12,15,17,19H,3-5,8-11H2,1-2H3/t15-,17+,18+/m0/s1 RHKNNDFXUCSIKD-CGTJXYLNSA-N 461968 Preparation of N-(17-methylmorphinan-3-yl)methanesulfonamide ::US10766864, Example 37 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461968&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690079 441293192 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953677 COc1ccc(NC(=O)c2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)cc1 InChI=1S/C25H30N2O2/c1-27-14-13-25-12-4-3-5-21(25)23(27)16-17-6-7-18(15-22(17)25)24(28)26-19-8-10-20(29-2)11-9-19/h6-11,15,21,23H,3-5,12-14,16H2,1-2H3,(H,26,28)/t21-,23+,25+/m0/s1 DAGGIZXNHYRAFA-QQKQFIJSSA-N 461969 Preparation of N-(4-methoxyphenyl)-17-methylmorphinan-3-carboxamide ::US10766864, Example 38 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461969&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690013 441293193 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953678 COCCOCCNC(=O)c1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C23H34N2O3/c1-25-11-9-23-8-4-3-5-19(23)21(25)16-17-6-7-18(15-20(17)23)22(26)24-10-12-28-14-13-27-2/h6-7,15,19,21H,3-5,8-14,16H2,1-2H3,(H,24,26)/t19-,21+,23+/m0/s1 KVRXLAPFKMRJDS-XKCSPQBFSA-N 461970 Preparation of N-[2-(2-methoxyethoxy)ethyl]-17-methylmorphinan-3-carboxamide ::US10766864, Example 39 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461970&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690036 441293194 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953679 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(NC(=O)OC(C)(C)C)cc31 InChI=1S/C22H32N2O2/c1-21(2,3)26-20(25)23-16-9-8-15-13-19-17-7-5-6-10-22(17,18(15)14-16)11-12-24(19)4/h8-9,14,17,19H,5-7,10-13H2,1-4H3,(H,23,25)/t17-,19+,22+/m0/s1 PXVPDOBANIVJQM-LRXVAGHRSA-N 461971 Preparation of tert-butyl (17-methylmorphinan-3-yl)carbamate ::US10766864, Example 40 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461971&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695630 441293195 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953680 COCCOCCOCCNC(=O)c1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C25H38N2O4/c1-27-11-9-25-8-4-3-5-21(25)23(27)18-19-6-7-20(17-22(19)25)24(28)26-10-12-30-15-16-31-14-13-29-2/h6-7,17,21,23H,3-5,8-16,18H2,1-2H3,(H,26,28)/t21-,23+,25+/m0/s1 DFDAHXVMYPJMPU-QQKQFIJSSA-N 461972 Preparation of N-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-17-methylmorphinan-3-carboxamide ::US10766864, Example 41 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461972&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690035 441293196 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953681 COCCOCCOCCOCCOCCOCC(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C30H48N2O7/c1-32-10-9-30-8-4-3-5-26(30)28(32)21-24-6-7-25(22-27(24)30)31-29(33)23-39-20-19-38-18-17-37-16-15-36-14-13-35-12-11-34-2/h6-7,22,26,28H,3-5,8-21,23H2,1-2H3,(H,31,33)/t26-,28+,30+/m0/s1 UMUJCZQCNAWYSH-CVXIRMMQSA-N 461973 Preparation of N-(17-methylmorphinan-3-yl)-2,5,8,11,14,17-hexaoxanonadecan-19-amide ::US10766864, Example 42 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461973&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134486943 441293197 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953682 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2cccnc2)cc31 InChI=1S/C22H27N3/c1-25-12-10-22-9-3-2-6-19(22)21(25)13-16-7-8-17(14-20(16)22)24-18-5-4-11-23-15-18/h4-5,7-8,11,14-15,19,21,24H,2-3,6,9-10,12-13H2,1H3/t19-,21+,22+/m0/s1 CKKURZGXXLJGDQ-KSEOMHKRSA-N 461974 Preparation of 17-methyl-N-(pyridin-3-yl)morphinan-3-amine ::US10766864, Example 43 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461974&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690081 441293198 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953683 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)-c1cn[nH]c1 461975 Preparation of 17-methyl-3-(1H-pyrazol-4-yl)morphinan ::US10766864, Example 44 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461975&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690080 441293199 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953684 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)-c1ccncc1 InChI=1S/C22H26N2/c1-24-13-10-22-9-3-2-4-19(22)21(24)15-18-6-5-17(14-20(18)22)16-7-11-23-12-8-16/h5-8,11-12,14,19,21H,2-4,9-10,13,15H2,1H3/t19-,21+,22+/m0/s1 TUALFXRCEKLSEG-KSEOMHKRSA-N 461976 Preparation of 17-methyl-3-(pyridin-4-yl)morphinan ::US10766864, Example 45 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461976&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689987 441293200 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953685 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2nccs2)cc31 InChI=1S/C20H25N3S/c1-23-10-8-20-7-3-2-4-16(20)18(23)12-14-5-6-15(13-17(14)20)22-19-21-9-11-24-19/h5-6,9,11,13,16,18H,2-4,7-8,10,12H2,1H3,(H,21,22)/t16-,18+,20+/m0/s1 YYPXEZBQCQDIFT-ILZDJORESA-N 461977 Preparation of 17-methyl-N-(1,3-thiazol-2-yl)morphinan-3-amine ::US10766864, Example 46 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461977&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690062 441293201 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953686 COCCOCCOCCO[C@@H]1CCC2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3C)C1 InChI=1S/C24H37NO5/c1-25-8-7-24-17-20(30-14-13-29-12-11-28-10-9-27-2)5-6-21(24)23(25)15-18-3-4-19(26)16-22(18)24/h3-4,16,20-21,23,26H,5-15,17H2,1-2H3/t20-,21?,23-,24+/m1/s1 DRVQXPKAWCJOJN-FXXYKOEOSA-N 461978 Preparation of (6β)-6-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-17-methylmorphinan-3-ol ::US10766864, Example 47 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461978&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134486946 441293202 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953687 COCCOCCOc1cncc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)c1 InChI=1S/C27H37N3O3/c1-30-10-9-27-8-4-3-5-24(27)26(30)15-20-6-7-21(17-25(20)27)29-22-16-23(19-28-18-22)33-14-13-32-12-11-31-2/h6-7,16-19,24,26,29H,3-5,8-15H2,1-2H3/t24-,26+,27+/m0/s1 KPUVSYRPEVRSKP-WYMJOSIYSA-N 461979 Preparation of N-{5-[2-(2-methoxyethoxy)ethoxy]pyridin-3-yl}-17-methylmorphinan-3-amine ::US10766864, Example 48 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461979&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690038 441293203 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953688 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ccncc2)cc31 InChI=1S/C22H27N3/c1-25-13-10-22-9-3-2-4-19(22)21(25)14-16-5-6-18(15-20(16)22)24-17-7-11-23-12-8-17/h5-8,11-12,15,19,21H,2-4,9-10,13-14H2,1H3,(H,23,24)/t19-,21+,22+/m0/s1 XQBOQLFWEURSOA-KSEOMHKRSA-N 461980 Preparation of 17-methyl-N-(pyridin-4-yl)morphinan-3-amine ::US10766864, Example 49 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461980&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690058 441293204 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953689 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ccncn2)cc31 InChI=1S/C21H26N4/c1-25-11-9-21-8-3-2-4-17(21)19(25)12-15-5-6-16(13-18(15)21)24-20-7-10-22-14-23-20/h5-7,10,13-14,17,19H,2-4,8-9,11-12H2,1H3,(H,22,23,24)/t17-,19+,21+/m0/s1 VKQRPMZOEQRJHI-FBBABVLZSA-N 461981 Preparation of 17-methyl-N-(pyrimidin-4-yl)morphinan-3-amine ::US10766864, Example 50 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461981&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690075 441293205 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953690 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)-c1ccoc1 InChI=1S/C21H25NO/c1-22-10-9-21-8-3-2-4-18(21)20(22)13-16-6-5-15(12-19(16)21)17-7-11-23-14-17/h5-7,11-12,14,18,20H,2-4,8-10,13H2,1H3/t18-,20+,21+/m0/s1 QZJRBGLHWMSMFY-CEWLAPEOSA-N 461982 Preparation of 3-(3-furyl)-17-methylmorphinan ::US10766864, Example 51 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461982&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689978 441293206 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953691 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)-c1cnc(N)nc1 InChI=1S/C21H26N4/c1-25-9-8-21-7-3-2-4-17(21)19(25)11-15-6-5-14(10-18(15)21)16-12-23-20(22)24-13-16/h5-6,10,12-13,17,19H,2-4,7-9,11H2,1H3,(H2,22,23,24)/t17-,19+,21+/m0/s1 MONSGXFZAAWXHZ-FBBABVLZSA-N 461983 Preparation of 5-(17-methylmorphinan-3-yl)pyrimidin-2-amine ::US10766864, Example 52 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461983&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690040 441293207 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953692 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2cncnc2)cc31 InChI=1S/C21H26N4/c1-25-9-8-21-7-3-2-4-18(21)20(25)10-15-5-6-16(11-19(15)21)24-17-12-22-14-23-13-17/h5-6,11-14,18,20,24H,2-4,7-10H2,1H3/t18-,20+,21+/m0/s1 IOQYMPDRXDDAHE-CEWLAPEOSA-N 461984 Preparation of 17-methyl-N-(pyrimidin-5-yl)morphinan-3-amine ::US10766864, Example 53 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461984&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695560 441293208 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953693 COCCOCCOCCOCCOCCOc1cncc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)c1 InChI=1S/C33H49N3O6/c1-36-10-9-33-8-4-3-5-30(33)32(36)21-26-6-7-27(23-31(26)33)35-28-22-29(25-34-24-28)42-20-19-41-18-17-40-16-15-39-14-13-38-12-11-37-2/h6-7,22-25,30,32,35H,3-5,8-21H2,1-2H3/t30-,32+,33+/m0/s1 NWODTPDXLFONNU-FCIJAXDVSA-N 461985 Preparation of (4bR,8aR,9R)—N-(5-(2,5,8,11,14-pentaoxahexadecan-16-yloxy)pyridin-3-yl)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-amine ::US10766864, Example 54 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461985&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695633 441293209 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953694 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2cnccn2)cc31 InChI=1S/C21H26N4/c1-25-11-8-21-7-3-2-4-17(21)19(25)12-15-5-6-16(13-18(15)21)24-20-14-22-9-10-23-20/h5-6,9-10,13-14,17,19H,2-4,7-8,11-12H2,1H3,(H,23,24)/t17-,19+,21+/m0/s1 IJYSFWGIKWABGZ-FBBABVLZSA-N 461986 Preparation of 17-methyl-N-(pyrazin-2-yl)morphinan-3-amine ::US10766864, Example 55 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461986&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690022 441293210 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953695 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ccnnc2)cc31 InChI=1S/C21H26N4/c1-25-11-9-21-8-3-2-4-18(21)20(25)12-15-5-6-16(13-19(15)21)24-17-7-10-22-23-14-17/h5-7,10,13-14,18,20H,2-4,8-9,11-12H2,1H3,(H,22,24)/t18-,20+,21+/m0/s1 KWXQCUSYHYZZEP-CEWLAPEOSA-N 461987 Preparation of 17-methyl-N-(pyridazin-4-yl)morphinan-3-amine ::US10766864, Example 56 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461987&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690054 441293211 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953696 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)N(c1ccccn1)c1ccccn1 InChI=1S/C27H30N4/c1-30-17-14-27-13-5-2-8-22(27)24(30)18-20-11-12-21(19-23(20)27)31(25-9-3-6-15-28-25)26-10-4-7-16-29-26/h3-4,6-7,9-12,15-16,19,22,24H,2,5,8,13-14,17-18H2,1H3/t22-,24+,27+/m0/s1 BPWMEURAYKTELK-CAKYRVLISA-N 461988 Preparation of 17-methyl-N,N-di(pyridin-2-yl)morphinan-3-amine ::US10766864, Example 57 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461988&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690028 441293212 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953697 COCCOCCOc1ccc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)cn1 InChI=1S/C27H37N3O3/c1-30-12-11-27-10-4-3-5-23(27)25(30)17-20-6-7-21(18-24(20)27)29-22-8-9-26(28-19-22)33-16-15-32-14-13-31-2/h6-9,18-19,23,25,29H,3-5,10-17H2,1-2H3/t23-,25+,27+/m0/s1 DCGOBNGIKSHTOP-VXQMPNGUSA-N 461989 Preparation of N-{6-[2-(2-methoxyethoxy)ethoxy]pyridin-3-yl}-17-methylmorphinan-3-amine ::US10766864, Example 58 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461989&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690016 441293213 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953698 COCCNc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C20H30N2O/c1-22-11-9-20-8-4-3-5-17(20)19(22)13-15-6-7-16(14-18(15)20)21-10-12-23-2/h6-7,14,17,19,21H,3-5,8-13H2,1-2H3/t17-,19+,20+/m0/s1 RODIJVGDZYQGSX-DFQSSKMNSA-N 461990 Preparation of N-(2-methoxyethyl)-17-methylmorphinan-3-amine ::US10766864, Example 59 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461990&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690107 441293214 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953699 COCCOCCOCCOCCOCCNc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C28H46N2O5/c1-30-11-9-28-8-4-3-5-25(28)27(30)21-23-6-7-24(22-26(23)28)29-10-12-32-15-16-34-19-20-35-18-17-33-14-13-31-2/h6-7,22,25,27,29H,3-5,8-21H2,1-2H3/t25-,27+,28+/m0/s1 ANBUQKJNVMRWKH-KJYTXNCISA-N 461991 17-methyl-3-(2,5,8,11,14-pentaoxahexadecan-16-yloxy)morphinan ::US10766864, Example 60 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461991&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695632 441293215 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953700 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2cccnn2)cc31 InChI=1S/C21H26N4/c1-25-12-10-21-9-3-2-5-17(21)19(25)13-15-7-8-16(14-18(15)21)23-20-6-4-11-22-24-20/h4,6-8,11,14,17,19H,2-3,5,9-10,12-13H2,1H3,(H,23,24)/t17-,19+,21+/m0/s1 WCUYMTZQGXZETI-FBBABVLZSA-N 461992 Preparation of 17-methyl-N-(pyridazin-3-yl)morphinan-3-amine ::US10766864, Example 61 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461992&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690039 441293216 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953701 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)-n1ccnc1 InChI=1S/C20H25N3/c1-22-10-8-20-7-3-2-4-17(20)19(22)12-15-5-6-16(13-18(15)20)23-11-9-21-14-23/h5-6,9,11,13-14,17,19H,2-4,7-8,10,12H2,1H3/t17-,19+,20+/m0/s1 VGCJOLCYMLOJTB-DFQSSKMNSA-N 461993 Preparation of 3-(1H-imidazol-1-yl)-17-methylmorphinan ::US10766864, Example 62 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461993&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690109 441293217 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953702 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ccccn2)cc31 InChI=1S/C22H27N3/c1-25-13-11-22-10-4-2-6-18(22)20(25)14-16-8-9-17(15-19(16)22)24-21-7-3-5-12-23-21/h3,5,7-9,12,15,18,20H,2,4,6,10-11,13-14H2,1H3,(H,23,24)/t18-,20+,22+/m0/s1 OGBLWRYSVDHZAP-CZTZKLFOSA-N 461994 Preparation of 17-methyl-N-(pyridin-2-yl)morphinan-3-amine ::US10766864, Example 63 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461994&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690010 441293218 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953703 COCCOCCOCCOCCOCCOc1ccc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)cn1 InChI=1S/C33H49N3O6/c1-36-12-11-33-10-4-3-5-29(33)31(36)23-26-6-7-27(24-30(26)33)35-28-8-9-32(34-25-28)42-22-21-41-20-19-40-18-17-39-16-15-38-14-13-37-2/h6-9,24-25,29,31,35H,3-5,10-23H2,1-2H3/t29-,31+,33+/m0/s1 DYPJEZFFUVQHGU-KCTCJIHVSA-N 461995 Preparation of 17-methyl-N-[6-(2,5,8,11,14-pentaoxahexadecan-16-yloxy)pyridin-3-yl]morphinan-3-amine ::US10766864, Example 64 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461995&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689985 441293219 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953704 COCCOCCn1cc(cn1)-c1ccc2CC3C4CCCCC4(CCN3C)c2c1 InChI=1S/C25H35N3O2/c1-27-10-9-25-8-4-3-5-22(25)24(27)16-20-7-6-19(15-23(20)25)21-17-26-28(18-21)11-12-30-14-13-29-2/h6-7,15,17-18,22,24H,3-5,8-14,16H2,1-2H3 GSUHACPRJUGMRQ-UHFFFAOYSA-N 461996 Preparation of 3-{1-[2-(2-methoxyethoxy)ethyl]-1H-pyrazol-4-yl}-17-methylmorphinan ::US10766864, Example 65 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461996&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695612 441293220 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953705 COCCOCCOc1cnccc1Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C27H37N3O3/c1-30-12-10-27-9-4-3-5-22(27)25(30)17-20-6-7-21(18-23(20)27)29-24-8-11-28-19-26(24)33-16-15-32-14-13-31-2/h6-8,11,18-19,22,25H,3-5,9-10,12-17H2,1-2H3,(H,28,29)/t22-,25+,27+/m0/s1 KLESJSNAGIGBAY-GEWUYGHSSA-N 461997 Preparation of (4bR,8aR,9R)—N-(3-(2-(2-methoxyethoxy)ethoxy)pyridin-4-yl)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-amine (6α), hydrochloride salt::US10766864, Example 66 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461997&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695613 441293221 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953706 COCCOCCOc1cc(Nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2)ccn1 InChI=1S/C27H37N3O3/c1-30-12-10-27-9-4-3-5-23(27)25(30)17-20-6-7-21(18-24(20)27)29-22-8-11-28-26(19-22)33-16-15-32-14-13-31-2/h6-8,11,18-19,23,25H,3-5,9-10,12-17H2,1-2H3,(H,28,29)/t23-,25+,27+/m0/s1 RBHOXGFHKHYUKX-VXQMPNGUSA-N 461998 Preparation of N-{2-[2-(2-methoxyethoxy)ethoxy]pyridin-4-yl}-17-methylmorphinan-3-amine ::US10766864, Example 67 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461998&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690050 441293222 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953707 COCCOCCOCC(=O)Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4C)cc2s1 InChI=1S/C25H35N3O4S/c1-28-8-7-25-6-4-3-5-18(25)21(28)13-17-14-22-20(15-19(17)25)26-24(33-22)27-23(29)16-32-12-11-31-10-9-30-2/h14-15,18,21H,3-13,16H2,1-2H3,(H,26,27,29)/t18-,21+,25+/m0/s1 XOVJSVCEBWUDBP-NXQMDHLFSA-N 461999 Preparation of 2-[2-(2-methoxyethoxy)ethoxy]-N— [(4aR,5R,11bR)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d][1,3]thiazol-9-yl]acetamide ::US10766864, Example 68 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=461999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=461999&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695614 441293223 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953708 COCCOCCOCCOCCOCCOCC(=O)Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4C)cc2s1 InChI=1S/C31H47N3O7S/c1-34-8-7-31-6-4-3-5-24(31)27(34)19-23-20-28-26(21-25(23)31)32-30(42-28)33-29(35)22-41-18-17-40-16-15-39-14-13-38-12-11-37-10-9-36-2/h20-21,24,27H,3-19,22H2,1-2H3,(H,32,33,35)/t24-,27+,31+/m0/s1 CWUKEXMRQFESRE-MUTQCRLMSA-N 462000 Preparation of 2-[2-(2-methoxyethoxy)ethoxy]-N— [(4aR,5R,11bR)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d][1,3]thiazol-9-yl]-2,5,8,11,14,17-hexaoxanonadecan-19-amide ::US10766864, Example 69 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462000&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134486949 441293224 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953709 COCCOCCOCCNc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4C)cc2s1 InChI=1S/C25H37N3O3S/c1-28-9-7-25-6-4-3-5-19(25)22(28)15-18-16-23-21(17-20(18)25)27-24(32-23)26-8-10-30-13-14-31-12-11-29-2/h16-17,19,22H,3-15H2,1-2H3,(H,26,27)/t19-,22+,25+/m0/s1 NLQGUOCGUWIBIR-UWUFEASWSA-N 462001 Preparation of (4aR,5R,11bR)—N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d]thiazol-9-amine ::US10766864, Example 71 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462001&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695616 441293225 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953710 COCCNC(=O)Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4C)cc2s1 InChI=1S/C22H30N4O2S/c1-26-9-7-22-6-4-3-5-15(22)18(26)11-14-12-19-17(13-16(14)22)24-21(29-19)25-20(27)23-8-10-28-2/h12-13,15,18H,3-11H2,1-2H3,(H2,23,24,25,27)/t15-,18+,22+/m0/s1 GKRGPMHMCSCLMS-QXATTWAWSA-N 462002 Preparation of 1-(2-methoxyethyl)-3-((4aR,5R,11bR)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d]thiazol-9-yl)urea ::US10766864, Example 72 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462002&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695559 441293226 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953711 COCCOc1cc2C[C@@H]3C4CCCC[C@]4(CCN3C)c2cc1O InChI=1S/C20H29NO3/c1-21-8-7-20-6-4-3-5-15(20)17(21)11-14-12-19(24-10-9-23-2)18(22)13-16(14)20/h12-13,15,17,22H,3-11H2,1-2H3/t15?,17-,20-/m1/s1 GJMFSVUQMOIKSL-LQRGHNGLSA-N 462003 Preparation of 2-(2-methoxyethoxy)-17-methylmorphinan-3-ol ::US10766864, Example 73 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462003&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134486950 441293227 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953712 COCCOc1cc(O)cc2c1C[C@@H]1[C@@H]3CCCC[C@]23CCN1C InChI=1S/C20H29NO3/c1-21-8-7-20-6-4-3-5-16(20)18(21)13-15-17(20)11-14(22)12-19(15)24-10-9-23-2/h11-12,16,18,22H,3-10,13H2,1-2H3/t16-,18+,20+/m0/s1 WJMWUHVGXXDCCJ-ILZDJORESA-N 462004 Preparation of 1-(2-methoxyethoxy)-17-methylmorphinan-3-ol ::US10766864, Example 74 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462004&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690053 441293228 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953713 COCCOCCOCCO[C@H]1CCC[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]12CCN3C InChI=1S/C24H37NO5/c1-25-9-8-24-20(22(25)16-18-6-7-19(26)17-21(18)24)4-3-5-23(24)30-15-14-29-13-12-28-11-10-27-2/h6-7,17,20,22-23,26H,3-5,8-16H2,1-2H3/t20-,22+,23-,24-/m0/s1 BZTZWILYFGXIMZ-IGABQKFOSA-N 462005 Preparation of (5α)-5-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-17-methylmorphinan-3-ol ::US10766864, Example 75 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462005&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690026 441293229 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953714 COCCNc1cc2c(C[C@@H]3[C@@H]4CCCC[C@]24CCN3C)cc1[N+]([O-])=O InChI=1S/C20H29N3O3/c1-22-9-7-20-6-4-3-5-15(20)18(22)11-14-12-19(23(24)25)17(13-16(14)20)21-8-10-26-2/h12-13,15,18,21H,3-11H2,1-2H3/t15-,18+,20+/m0/s1 KSHKRQDIKGUHKX-QKYXUNIQSA-N 462006 Preparation of N-(2-methoxyethyl)-17-methyl-2-nitromorphinan-3-amine ::US10766864, Example 76 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462006&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690042 441293230 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953715 COCCOCCOCCOCCOCCNc1nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2s1 InChI=1S/C29H45N3O5S/c1-32-11-9-29-8-4-3-5-23(29)25(32)21-22-6-7-24-27(26(22)29)38-28(31-24)30-10-12-34-15-16-36-19-20-37-18-17-35-14-13-33-2/h6-7,23,25H,3-5,8-21H2,1-2H3,(H,30,31)/t23-,25+,29+/m0/s1 JWEMIEDKYWEOKW-ZLZBJJAKSA-N 462007 Preparation of (7R,7aR,11aR)—N-(2,5,8,11,14-pentaoxahexadecan-16-yl)-14-methyl-7,7a,8,9,10,11-hexahydro-6H-7,11a-(epiminoethano)phenanthro[3,4-d]thiazol-2-amine ::US10766864, Example 77 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462007&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695576 441293231 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953716 COCCOCCOCCNc1nc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4C)c3c2s1 InChI=1S/C25H37N3O3S/c1-28-11-9-25-8-4-3-5-19(25)21(28)17-18-6-7-20-23(22(18)25)32-24(27-20)26-10-12-30-15-16-31-14-13-29-2/h6-7,19,21H,3-5,8-17H2,1-2H3,(H,26,27)/t19-,21+,25+/m0/s1 WQASNRGGHKKUAQ-PIBDYAPNSA-N 462008 Preparation of (7R,7aR,11aR)—N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-14-methyl-7,7a,8,9,10,11-hexahydro-6H-7,11a-(epiminoethano)phenanthro[3,4-d]thiazol-2-amine ::US10766864, Example 78 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462008&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695634 441293232 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953717 COCCOCCC(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)c2c1 InChI=1S/C23H34N2O3/c1-25-11-10-23-9-4-3-5-19(23)21(25)15-17-6-7-18(16-20(17)23)24-22(26)8-12-28-14-13-27-2/h6-7,16,19,21H,3-5,8-15H2,1-2H3,(H,24,26)/t19-,21+,23+/m0/s1 PPEVMIUSHIHTJR-XKCSPQBFSA-N 462009 3-(2-methoxyethoxy)-N-((4bR,8aR,9R)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-yl)propanamide ::US10766864, Example 79 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462009&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695631 441293233 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953718 COCCOCCOCCOCCOCCCC(=O)Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4C)cc2s1 InChI=1S/C31H47N3O6S/c1-34-10-9-31-8-4-3-6-24(31)27(34)20-23-21-28-26(22-25(23)31)32-30(41-28)33-29(35)7-5-11-37-14-15-39-18-19-40-17-16-38-13-12-36-2/h21-22,24,27H,3-20H2,1-2H3,(H,32,33,35)/t24-,27+,31+/m0/s1 WYCJXHSUOORFCQ-MUTQCRLMSA-N 462010 Preparation of N-[(4aR,5R,11bR)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d][1,3]thiazol-9-yl]-2,5,8,11,14-pentaoxaoctadecan-18-amide ::US10766864, Example 80 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462010&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134486953 441293234 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953719 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2nc[nH]c2cc31 462011 Preparation of (4aR,5R,11bR)-14-methyl-1,2,3,4,4a,5,6,10-octahydro-5,11b-(epiminoethano)phenanthro[2,3-d]imidazole ::US10766864, Example 81 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462011&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695635 441293235 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953720 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2nc(N)[nH]c2cc31 462012 Preparation of (4aR,5R,11bR)-14-methyl-1,2,3,4,4a,5,6,10-octahydro-5,11b-(epiminoethano)phenanthro[2,3-d]imidazol-9-amine ::US10766864, Example 82 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462012&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695580 441293236 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953721 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2cccnc2)cc31 InChI=1S/C26H35N3O2/c1-30-15-16-31-14-13-29-12-10-26-9-3-2-6-23(26)25(29)17-20-7-8-21(18-24(20)26)28-22-5-4-11-27-19-22/h4-5,7-8,11,18-19,23,25,28H,2-3,6,9-10,12-17H2,1H3/t23-,25+,26+/m0/s1 BTJOQHJNZXDUAU-SKBVVQJISA-N 462013 Preparation of 17-[2-(2-methoxyethoxy)ethyl]-N-(pyridin-3-yl)morphinan-3-amine ::US10766864, Example 83 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462013&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690001 441293237 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953722 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2sc(NC(N)=N)nc2cc31 InChI=1S/C19H25N5S/c1-24-7-6-19-5-3-2-4-12(19)15(24)8-11-9-16-14(10-13(11)19)22-18(25-16)23-17(20)21/h9-10,12,15H,2-8H2,1H3,(H4,20,21,22,23)/t12-,15+,19+/m0/s1 UVHUCUKOWJBUGQ-IOHHAYIISA-N 462014 Preparation of 1-((4aR,5R,11bR)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d]thiazol-9-yl)guanidine ::US10766864, Example 84 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462014&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695636 441293238 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953723 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2sc(NC(=O)C4CCN(CC4)C(=O)OC(C)(C)C)nc2cc31 InChI=1S/C29H40N4O3S/c1-28(2,3)36-27(35)33-12-8-18(9-13-33)25(34)31-26-30-22-17-21-19(16-24(22)37-26)15-23-20-7-5-6-10-29(20,21)11-14-32(23)4/h16-18,20,23H,5-15H2,1-4H3,(H,30,31,34)/t20-,23+,29+/m0/s1 NCLSCLDZWBLRKD-YOLRXJNRSA-N 462015 Preparation of tert-butyl 4-{[(4aR,5R,11bR)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d][1,3]thiazol-9-yl]carbamoyl}piperidine-1-carboxylate ::US10766864, Example 85 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462015&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134486954 441293239 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953724 COCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2cccnc2)cc31 InChI=1S/C24H31N3O/c1-28-14-13-27-12-10-24-9-3-2-6-21(24)23(27)15-18-7-8-19(16-22(18)24)26-20-5-4-11-25-17-20/h4-5,7-8,11,16-17,21,23,26H,2-3,6,9-10,12-15H2,1H3/t21-,23+,24+/m0/s1 UJQLEUAQSTWSCQ-QPTUXGOLSA-N 462016 Preparation of 17-(2-methoxyethyl)-N-(pyridin-3-yl)morphinan-3-amine ::US10766864, Example 86 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462016&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689983 441293240 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953725 Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C3COC3)c2c1 InChI=1S/C19H25NO2/c21-15-5-4-13-9-18-16-3-1-2-6-19(16,17(13)10-15)7-8-20(18)14-11-22-12-14/h4-5,10,14,16,18,21H,1-3,6-9,11-12H2/t16-,18+,19+/m0/s1 XACJBOULEVXTTP-QXAKKESOSA-N 462017 Preparation of 17-(oxetan-3-yl)morphinan-3-ol ::US10766864, Example 87 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462017&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690023 441293241 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953726 Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC3COC3)c2c1 InChI=1S/C20H27NO2/c22-16-5-4-15-9-19-17-3-1-2-6-20(17,18(15)10-16)7-8-21(19)11-14-12-23-13-14/h4-5,10,14,17,19,22H,1-3,6-9,11-13H2/t17-,19+,20+/m0/s1 RTGBFYXGEAQCNA-DFQSSKMNSA-N 462018 Preparation of 17-(oxetan-3-ylmethyl)morphinan-3-ol ::US10766864, Example 88 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462018&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122689992 441293242 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953727 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2cccnc2cc31 InChI=1S/C20H24N2/c1-22-10-8-20-7-3-2-6-16(20)19(22)12-15-11-14-5-4-9-21-18(14)13-17(15)20/h4-5,9,11,13,16,19H,2-3,6-8,10,12H2,1H3/t16-,19+,20+/m0/s1 CPIXYNBRHVNTNN-PWIZWCRZSA-N 462019 Preparation of (4aR,5R,12bR)-15-methyl-2,3,4,4a,5,6-hexahydro-1H-5,12b-(epiminoethano)naphtho[2,1-g]quinoline ::US10766864, Example 89 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462019&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695561 441293243 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953728 CN1CC[C@]23Cc4nc(N)sc4C[C@H]2[C@H]1Cc1ccc(O)cc31 InChI=1S/C18H21N3OS/c1-21-5-4-18-9-14-16(23-17(19)20-14)8-13(18)15(21)6-10-2-3-11(22)7-12(10)18/h2-3,7,13,15,22H,4-6,8-9H2,1H3,(H2,19,20)/t13-,15+,18+/m0/s1 LVYYHBPAWFABPE-JCKWVBRZSA-N 50212299 (1S,9R,10R)-5-amino-20-methyl-6-thia-4,20-diazapentacyclo[8.7.3.0^{1,9}.0^{3,7}.0^{12,17}]icosa-3(7),4,12(17),13,15-pentaen-15-ol::CHEMBL226167::US10766864, Example 90 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50212299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50212299&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 16720649 104088244 CHEMBL226167 ZINC28646636 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953729 Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC3CCO3)c2c1 InChI=1S/C20H27NO2/c22-15-5-4-14-11-19-17-3-1-2-7-20(17,18(14)12-15)8-9-21(19)13-16-6-10-23-16/h4-5,12,16-17,19,22H,1-3,6-11,13H2/t16?,17-,19+,20+/m0/s1 MUGKLXUJZFCIQV-KSRCZVEISA-N 462021 Preparation of 17-(oxetan-2-ylmethyl)morphinan-3-ol ::US10766864, Example 91 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462021&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690069 441293245 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953730 COCCNC(=N)Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4C)cc2s1 InChI=1S/C22H31N5OS/c1-27-9-7-22-6-4-3-5-15(22)18(27)11-14-12-19-17(13-16(14)22)25-21(29-19)26-20(23)24-8-10-28-2/h12-13,15,18H,3-11H2,1-2H3,(H3,23,24,25,26)/t15-,18+,22+/m0/s1 VRANSLSVODJKTA-QXATTWAWSA-N 462022 1-(2-methoxyethyl)-3-((4aR,5R,11bR)-14-methyl-2,3,4,4a,5,6-hexahydro-1H-5,11b-(epiminoethano)phenanthro[3,2-d]thiazol-9-yl)guanidine ::US10766864, Example 92 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462022&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695562 441293246 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953731 COCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ccncc2)cc31 InChI=1S/C24H31N3O/c1-28-15-14-27-13-10-24-9-3-2-4-21(24)23(27)16-18-5-6-20(17-22(18)24)26-19-7-11-25-12-8-19/h5-8,11-12,17,21,23H,2-4,9-10,13-16H2,1H3,(H,25,26)/t21-,23+,24+/m0/s1 RVLZSXXTLPHBIC-QPTUXGOLSA-N 462023 Preparation of 17-(2-methoxyethyl)-N-(pyridin-4-yl)morphinan-3-amine ::US10766864, Example 93 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462023&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690087 441293247 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953732 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2ncc(N)nc2cc31 InChI=1S/C19H24N4/c1-23-7-6-19-5-3-2-4-13(19)17(23)9-12-8-15-16(10-14(12)19)22-18(20)11-21-15/h8,10-11,13,17H,2-7,9H2,1H3,(H2,20,22)/t13-,17+,19+/m0/s1 DUPQGPZNUFLJCF-BOFPYLFWSA-N 462024 Preparation of (4aR,5R,12bR)-15-methyl-2,3,4,4a,5,6-hexahydro-1H-5,12b-(epiminoethano)naphtho[1,2-g]quinoxalin-10-amine ::US10766864, Example 94 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462024&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695564 441293248 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953733 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2nnc(N)nc2cc31 InChI=1S/C18H23N5/c1-23-7-6-18-5-3-2-4-12(18)16(23)9-11-8-15-14(10-13(11)18)20-17(19)22-21-15/h8,10,12,16H,2-7,9H2,1H3,(H2,19,20,22)/t12-,16+,18+/m0/s1 OKMNPEFDTMKVCQ-BJOOFOGMSA-N 462025 Preparation of (4aR,5R,12bR)-15-methyl-2,3,4,4a,5,6-hexahydro-1H-5,12b-(epiminoethano)phenanthro[3,2-e][1,2,4]triazin-10-amine ::US10766864, Example 95 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462025&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690064 441293249 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953734 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(N)cc31 InChI=1S/C21H32N2O2/c1-24-12-13-25-11-10-23-9-8-21-7-3-2-4-18(21)20(23)14-16-5-6-17(22)15-19(16)21/h5-6,15,18,20H,2-4,7-14,22H2,1H3/t18-,20+,21+/m0/s1 VMIWHFQJHHSOSR-CEWLAPEOSA-N 462026 US10766864, Example 96 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462026&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695563 441293250 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953735 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2sc(N)nc2cc31 InChI=1S/C22H31N3O2S/c1-26-10-11-27-9-8-25-7-6-22-5-3-2-4-16(22)19(25)12-15-13-20-18(14-17(15)22)24-21(23)28-20/h13-14,16,19H,2-12H2,1H3,(H2,23,24)/t16-,19+,22+/m0/s1 MSKNNQUPDKTVGU-DKZVUGQWSA-N 462027 Preparation of (4aR,5R,11bR)-14-(2-(2-methoxyethoxy)ethyl)-2,3,4,4a,5,6-hexahydro-1H-5,10-(epiminoethano)phenanthro[3,2-d]thiazol-9-amine ::US10766864, Example 97 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462027&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695581 441293251 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953736 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ccncc2)cc31 InChI=1S/C26H35N3O2/c1-30-16-17-31-15-14-29-13-10-26-9-3-2-4-23(26)25(29)18-20-5-6-22(19-24(20)26)28-21-7-11-27-12-8-21/h5-8,11-12,19,23,25H,2-4,9-10,13-18H2,1H3,(H,27,28)/t23-,25+,26+/m0/s1 IVUYTIOTZPFQNJ-SKBVVQJISA-N 462028 Preparation of 17-[2-(2-methoxyethoxy)ethyl]-N-(pyridin-4-yl)morphinan-3-amine ::US10766864, Example 98 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462028&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690017 441293252 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953737 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2ccnnc2)cc31 InChI=1S/C25H34N4O2/c1-30-14-15-31-13-12-29-11-9-25-8-3-2-4-22(25)24(29)16-19-5-6-20(17-23(19)25)28-21-7-10-26-27-18-21/h5-7,10,17-18,22,24H,2-4,8-9,11-16H2,1H3,(H,26,28)/t22-,24+,25+/m0/s1 HJWUNVQEAYMLGM-ICDZXHCJSA-N 462029 Preparation of (4bR,8aR,9R)-11-(2-(2-methoxyethoxy)ethyl)-N-(pyridazin-4-yl)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-amine ::US10766864, Example 99 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462029&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695605 441293253 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953738 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)-c1cn[nH]c1 462030 Preparation of (4bR,8aR,9R)-11-(2-(2-methoxyethoxy)ethyl)-3-(1H-pyrazol-4-yl)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene ::US10766864, Example 100 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462030&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695639 441293254 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953739 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2ccc(N)nc2cc31 InChI=1S/C20H25N3/c1-23-9-8-20-7-3-2-4-15(20)18(23)11-14-10-13-5-6-19(21)22-17(13)12-16(14)20/h5-6,10,12,15,18H,2-4,7-9,11H2,1H3,(H2,21,22)/t15-,18+,20+/m0/s1 BCQNZUSAYWXZOS-QKYXUNIQSA-N 462031 Preparation of (4aR,5R,12bR)-15-methyl-2,3,4,4a,5,6-hexahydro-1H-5,12b-(epiminoethano)naphtho[2,1-g]quinolin-10-amine ::US10766864, Example 101 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462031&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695640 441293255 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953740 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2ccc(=O)[nH]c2cc31 462032 Preparation of (4aR,5R,12bR)-15-methyl-1,2,3,4,4a,5,6,11-octahydro-10H-5,12b-(epiminoethano)naphtho[2,1-g]quinolin-10-one ::US10766864, Example 102 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462032&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155903587 441293256 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953741 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc(C#N)c(N)cc31 InChI=1S/C18H23N3/c1-21-7-6-18-5-3-2-4-14(18)17(21)9-12-8-13(11-19)16(20)10-15(12)18/h8,10,14,17H,2-7,9,20H2,1H3/t14-,17+,18+/m0/s1 IAUAZASZAPERRT-BMGDILEWSA-N 462033 Preparation of 3-amino-17-methylmorphinan-2-carbonitrile ::US10766864, Example 103 Mu-type opioid receptor Homo sapiens >1000 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462033&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690074 441293257 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953742 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2cncc(F)c2)cc31 InChI=1S/C26H34FN3O2/c1-31-12-13-32-11-10-30-9-8-26-7-3-2-4-23(26)25(30)14-19-5-6-21(16-24(19)26)29-22-15-20(27)17-28-18-22/h5-6,15-18,23,25,29H,2-4,7-14H2,1H3/t23-,25+,26+/m0/s1 CCFHDVWKLJXWCM-SKBVVQJISA-N 462034 Preparation of 17-[2-(2-methoxyethoxy)ethyl]-N-(5-fluoro-pyridin-3-yl)morphinan-3-amine ::US10766864, Example 104 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462034&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690024 441293258 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953743 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(Nc2nccs2)cc31 InChI=1S/C24H33N3O2S/c1-28-13-14-29-12-11-27-10-8-24-7-3-2-4-20(24)22(27)16-18-5-6-19(17-21(18)24)26-23-25-9-15-30-23/h5-6,9,15,17,20,22H,2-4,7-8,10-14,16H2,1H3,(H,25,26)/t20-,22+,24+/m0/s1 QLECEANEMQBWRJ-BGWNEDDSSA-N 462035 Preparation of N-((4bR,8aR,9R)-11-(2-(2-methoxyethoxy)ethyl)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-yl)thiazol-2-amine ::US10766864, Example 105 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462035&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695582 441293259 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953744 COCCOCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)-c1ccoc1 InChI=1S/C25H33NO3/c1-27-14-15-28-13-11-26-10-9-25-8-3-2-4-22(25)24(26)17-20-6-5-19(16-23(20)25)21-7-12-29-18-21/h5-7,12,16,18,22,24H,2-4,8-11,13-15,17H2,1H3/t22-,24+,25+/m0/s1 SILMVTUHMWZGJA-ICDZXHCJSA-N 462036 Preparation of (4bR,8aR,9R)-3-(furan-3-yl)-11-(2-(2-methoxyethoxy)ethyl)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene ::US10766864, Example 106 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462036&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122695606 441293260 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953745 COCCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc31 InChI=1S/C19H27NO2/c1-22-11-10-20-9-8-19-7-3-2-4-16(19)18(20)12-14-5-6-15(21)13-17(14)19/h5-6,13,16,18,21H,2-4,7-12H2,1H3/t16-,18+,19+/m0/s1 BRIKJIUSSPUTGA-QXAKKESOSA-N 462037 Preparation of 3-hydroxy-17-(2-methoxyethyl)morphinan ::US10766864, Example 113 Mu-type opioid receptor Homo sapiens 5.0 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=462037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=462037&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122690003 441293261 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953746 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(N)cc31 InChI=1S/C17H24N2/c1-19-9-8-17-7-3-2-4-14(17)16(19)10-12-5-6-13(18)11-15(12)17/h5-6,11,14,16H,2-4,7-10,18H2,1H3/t14-,16+,17+/m0/s1 CYPHSPITDGFDMD-USXIJHARSA-N 50138010 3-Amino-N-methylmorphinan::CHEMBL48420::US10766864, Example 114 Mu-type opioid receptor Homo sapiens 550 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138010&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 15934554 104028148 CHEMBL48420 ZINC13532319 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 953747 CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1cc2sc(N)nc2cc31 InChI=1S/C18H23N3S/c1-21-7-6-18-5-3-2-4-12(18)15(21)8-11-9-16-14(10-13(11)18)20-17(19)22-16/h9-10,12,15H,2-8H2,1H3,(H2,19,20)/t12-,15+,18+/m0/s1 MFCKRIRSBAZCHR-WBHUJUFNSA-N 50341308 CHEMBL1766021::N-methyl-3-aminothiazolo-morphinan::US10766864, Example 115 Mu-type opioid receptor Homo sapiens 55 US Patent 10.7270/Q2MC932J aid1804796 US10766864 Anand, NK; Aurrecoechea, N; Cheng, L; Deng, B; O''Mahony, DJ; Mu, Y; Krogh-Jespersen, E 9/8/2020 4/26/2021 Nektar Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50341308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50341308&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 54583374 131344244 CHEMBL1766021 ZINC13560064 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57